Stay updated on NVG-111 in ROR1+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.

Latest updates to the NVG-111 in ROR1+ Malignancies Clinical Trial page
- CheckyesterdayChange DetectedDifference0.6%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference1.0%
- Check15 days agoChange DetectedDifference1%
- Check22 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed descriptions of the NVG-111 drug trial and its inclusion criteria, while retaining key cancer types and the EudraCT number. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference32%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference1%
- Check37 days agoChange DetectedDifference0.9%
Stay in the know with updates to NVG-111 in ROR1+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.